UBV
RVNC

United Bank (Virginia)’s Revance Therapeutics, Inc. RVNC Stock Holding History

United Bank (Virginia)’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-65,500
Closed -$1.06M – 51
2016
Q3 		$1.06M Sell
65,500
-11,677
-15% -$170K 1.14% 31
2016
Q2 		$1.05M Hold
77,177
– – 1.04% 36
2016
Q1 		$1.35M Hold
77,177
– – 1.35% 34
2015
Q4 		$2.64M Buy
+77,177
New +$2.68M 3.18% 9

Other funds holding RVNC

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

United Bank (Virginia)'s RVNC Position: Q4 2016 in Review

United Bank (Virginia) sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2016, closing a stake of 65,500 shares — an estimated $1.06M sold.

United Bank (Virginia) first reported a position in RVNC in Q4 2015 and held it in 4 quarters. The position peaked at $2.64M in Q4 2015. 81 funds tracked by Wall St. Rank hold RVNC as of Q4 2016.

  • United Bank (Virginia) reported no remaining Revance Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • United Bank (Virginia) sold 65,500 Revance Therapeutics, Inc. shares in Q4 2016, an estimated $1.06M.
  • United Bank (Virginia) first reported a position in Revance Therapeutics, Inc. in Q4 2015 and held it in 4 quarters.
  • United Bank (Virginia)'s Revance Therapeutics, Inc. position peaked at $2.64M in Q4 2015.
  • 81 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2016.

Based on United Bank (Virginia)'s 13F filing for Q4 2016, filed 30 Jan 2017.